Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma
Phase 3
Terminated
- Conditions
- Covid-19
- Interventions
- Biological: Anti SARS-CoV 2 Convalescent Plasma in severe COVID-19 patientsBiological: Anti SARS-CoV 2 Convalescent Plasma in critical COVID-19 patients
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- Centro Medico ABC
- Target Recruit Count
- 6
- Registration Number
- NCT04432103
- Locations
- π²π½
Centro Medico Abc, Mexico City, Mexico
Β© Copyright 2025. All Rights Reserved by MedPath